Myeloma does some things to your body that you should be aware of. Bone lesions, thickening of your blood, and damage to your kidneys are all things to watch out for. It’s also important to know how high-risk or low-risk your disease is, as this is playing an increasingly important part in myeloma treatment. Below are some video excerpts from our HealthTree University curriculum to help you learn more about these important areas of your disease.
If you register in HealthTree to use HealthTree University (where you can watch these same videos), you can save and keep track of your progress, get points for answering quiz questions, bookmark videos, take notes, earn prizes [COMING SOON], and get access to all the other features of HealthTree.
2.06 — What are lytic and focal bone lesions and how common are they?
The difference between a lytic and focal bone lesion is useful to know, especially if you have bone lesions at diagnosis.
Featuring:
Hyperviscosity is a symptom of high protein in your blood, and it is good to know the symptoms so you know what to look out for.
Featuring:
Kidney disease is one of the more common sites of organ damage due to myeloma, and it’s good to understand why this happens.
Featuring:
mSMART helps separate patients into risk groups, to help you know whether you’re at high risk or not.
Featuring:
Knowing your level of risk can give you an important tool to understand your future treatment paths.
Featuring:
We have over 200 HealthTree University videos online at university.healthtree.org! Learn the basics (and the not-so-basics) of myeloma from some of the top myeloma doctors in the world!
about the author
Cynthia Chmielewski
Cynthia Chmielewski is a professional educator and myeloma advocate. As a former teacher, she now teaches myeloma patients how to advocate for themselves as the Director of HealthTree University.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.